iCAD Inc (ICAD) – Strategy, SWOT and Corporate Finance Report

iCAD Inc (ICAD) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

iCAD Inc (iCAD) is a medical technology company that provides advanced image analysis, radiation therapies and workflow solutions for the early disclosure and treatment of cancers. The company offers cancer detection products and solutions which include Powerlook, VeraLook and ProFound AI and magnetic resonance imaging (MRI) applications for diagnostic purposes. It also provides Xoft System, a proprietary electronic brachytherapy platform for oncology treatment. The company uses artificial intelligence for its product development. iCAD operates in the US and markets products through direct sales organization, OEM partners, distributors and resellers in the US and abroad. iCAD is headquartered in Nashua, New Hampshire, the US.

Scope

• Detailed information on iCAD Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting iCAD Inc in the form of a SWOT analysis

• An in-depth view of the business model of iCAD Inc including a breakdown and examination of key business segments

• News about iCAD Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of iCAD Inc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess iCAD Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on iCAD Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Sensus Healthcare Inc

Densitas Inc.

ScreenPoint Medical BV

GE HealthCare Technologies Inc

Hologic Inc

Siemens Medical Solutions USA Inc

Volpara Health Technologies Ltd

Carl Zeiss Meditec AG

Varian Medical Systems Inc

Philips Healthcare

Intraop Medical Corporation

Elekta Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

iCAD Inc - Key Facts

iCAD Inc - Key Employees

iCAD Inc - Key Employee Biographies

iCAD Inc - Major Products and Services

iCAD Inc - History

iCAD Inc - Company Statement

iCAD Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

iCAD Inc - Business Description

Business Segment: Cancer Detection

Overview

Performance

Business Segment: Cancer Therapy

Overview

Performance

R&D Overview

iCAD Inc - Corporate Strategy

iCAD Inc - SWOT Analysis

SWOT Analysis - Overview

iCAD Inc - Strengths

iCAD Inc - Weaknesses

iCAD Inc - Opportunities

iCAD Inc - Threats

iCAD Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

iCAD Inc, Medical Equipment, Deals By Year, 2017 to YTD 2023

iCAD Inc, Medical Equipment, Deals By Type, 2017 to YTD 2023

iCAD Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

May 15, 2023: iCAD reports financial results for first quarter ended March 31, 2023

May 11, 2023: New long-term real-world research confirms Xoft Skin eBx is as safe and effective as Mohs Surgery

Apr 17, 2023: iCAD Strengthens Leadership Team with Appointment of Chief Financial Officer and New Senior Executives

Mar 28, 2023: iCAD Reports Financial Results for Fourth Quarter ended December 31, 2022 and Year End

Mar 13, 2023: iCAD Announces Leadership Transition

Mar 13, 2023: iCAD Previews Fourth Quarter Financial Results, Full Report on March 28, 2023

Dec 08, 2022: iCAD features Solis Mammography in upcoming “ProFound Insights, ProFound Impact” webinar

Nov 10, 2022: iCAD Reports Financial Results for Third Quarter Ended September 30, 2022

Oct 27, 2022: iCAD to Report Third Quarter 2022 Financial Results on November 10, 2022

Sep 07, 2022: iCAD To Participate in The Lake Street Capital Markets 6th Annual Best Ideas Growth (BIG6) Conference on September 14, 2022

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

iCAD Inc, Key Facts

iCAD Inc, Key Employees

iCAD Inc, Key Employee Biographies

iCAD Inc, Major Products and Services

iCAD Inc, History

iCAD Inc, Other Locations

iCAD Inc, Subsidiaries

iCAD Inc, Key Competitors

iCAD Inc, Ratios based on current share price

iCAD Inc, Annual Ratios

iCAD Inc, Annual Ratios (Cont…1)

iCAD Inc, Annual Ratios (Cont…2)

iCAD Inc, Interim Ratios

iCAD Inc, Medical Equipment, Deals By Year, 2017 to YTD 2023

iCAD Inc, Medical Equipment, Deals By Type, 2017 to YTD 2023

iCAD Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

iCAD Inc, Performance Chart (2018 – 2022)

iCAD Inc, Ratio Charts

iCAD Inc, Medical Equipment, Deals By Year, 2017 to YTD 2023

iCAD Inc, Medical Equipment, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports